CNR Institutional Research Information System

CONTASTA, IDA ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.297
NA - Nord America 902
SA - Sud America 297
EU - Europa 179
AF - Africa 29
OC - Oceania 4
Totale 2.708
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 877
SG - Singapore 578
CN - Cina 249
BR - Brasile 247
HK - Hong Kong 186
VN - Vietnam 119
IT - Italia 63
KR - Corea 46
IN - India 29
GB - Regno Unito 20
AR - Argentina 19
DE - Germania 18
ID - Indonesia 14
MX - Messico 13
BD - Bangladesh 12
NL - Olanda 12
FR - Francia 11
EC - Ecuador 10
FI - Finlandia 10
IQ - Iraq 9
JP - Giappone 9
CA - Canada 8
UA - Ucraina 8
IL - Israele 7
SA - Arabia Saudita 7
SE - Svezia 7
VE - Venezuela 7
JO - Giordania 6
KE - Kenya 6
MA - Marocco 6
PY - Paraguay 6
TR - Turchia 5
ZA - Sudafrica 5
AU - Australia 4
CO - Colombia 4
ES - Italia 4
PK - Pakistan 4
AL - Albania 3
AT - Austria 3
EG - Egitto 3
PL - Polonia 3
RS - Serbia 3
RU - Federazione Russa 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
IE - Irlanda 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
AM - Armenia 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
NP - Nepal 1
PE - Perù 1
RW - Ruanda 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 2.708
Salva come PNG Salva come JPEG
Città #
Santa Clara 630
Singapore 362
Hong Kong 183
Hefei 116
Beijing 75
Ho Chi Minh City 45
Seoul 44
Ashburn 34
Hanoi 32
São Paulo 30
Los Angeles 20
San Jose 19
Buffalo 14
Dallas 12
Helsinki 9
New York 8
Quito 7
Rio de Janeiro 7
Dhaka 6
Minamishinagawa 6
Nairobi 6
Frankfurt am Main 5
Riyadh 5
Stockholm 5
Thái Bình 5
Amman 4
Baghdad 4
Belo Horizonte 4
Bologna 4
Brasília 4
Chicago 4
Da Nang 4
Düsseldorf 4
Marigliano 4
Mumbai 4
Ourinhos 4
Phoenix 4
Porto Alegre 4
Rome 4
Asunción 3
Bengaluru 3
Biên Hòa 3
Boston 3
Brooklyn 3
Bình An 3
Campinas 3
Casablanca 3
Guayaquil 3
Ha Long 3
Houston 3
Jakarta 3
Johannesburg 3
Montevideo 3
Montreal 3
Osasco 3
Pescara 3
Pune 3
Quận Bình Thạnh 3
San Francisco 3
Serra 3
São Carlos 3
São Gonçalo 3
São José dos Campos 3
Tirana 3
Tokyo 3
Volta Redonda 3
Warsaw 3
Addis Ababa 2
Ankara 2
Atlanta 2
Baku 2
Barueri 2
Belgrade 2
Bogotá 2
Buenos Aires 2
Cabo Frio 2
Caracas 2
Charleston 2
Charlotte 2
Chieti 2
Criciúma 2
Curitiba 2
Denver 2
Dublin 2
Fort Worth 2
Genoa 2
Goiânia 2
Guarulhos 2
Hamad Town 2
Imperatriz 2
Itabaiana 2
Jackson 2
Jeddah 2
Juiz de Fora 2
Kyiv 2
London 2
Manchester 2
Mendoza 2
Mexico City 2
Milan 2
Totale 1.891
Salva come PNG Salva come JPEG
Nome #
Classification of cancer stage using the immune system. 87
Are Immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? 74
p53 and Ki-ras alterations in colorectal adenocarcinomas 66
Immunological mechanisms in the establishment and progression of colon cancer. 61
K-Ras mutations in colon adenocarcinomas 60
HLA class II genomic polymorphism in multiple sclerosis: evaluation of DQA-DPB alleles 52
CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance. 50
IL-8 involvement in immune disregulation of cancer patients 44
The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates. 43
The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy 43
CD30 Molecule, The Immune System and Multiple Sclerosis. 42
Tipizzazione per sequenza degli antigeni HLA di classe I e II nel trapianto di rene. 41
Polymorphism of DQA1 promoter in Italian population 38
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age 38
Medical research news in the understanding, diagnosis, treatment, cure or prevention of human disease: "Ageing gender-specific targets/biomarkers for the identification of drugs with specific gender-related action and more appropriate therapeutic strategies." 38
A gender-related action of IFNß-therapy was found in multiple sclerosis. 38
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy 37
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy 37
Identification of a recombination event by DNA heteroduplex in a bone marrow transplant familial study 36
Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients. 36
Novel Prognostic Biomarkers for Personalized Cancer Treatment 34
Immunological pathways in diagnosis, treatment, cure and prevention of human disease: "Gender-Specific Cytokine Pathways, Targets and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer" 34
Mutazioni di geni della famiglia ras nelle neoplasie del cavo orale e delle ghiandole annesse. 33
Medical research news in the understanding, diagnosis, treatment, cure or prevention of cancer disease: "ARE IMMUNOLOGICAL MECHANISMS INVOLVED IN COLON CANCER AND ARE THEY POSSIBLE MARKERS FOR BIOTHERAPY IMPROVEMENT?" 33
Anti-HLA antibodies after soluble antigens absorption, genomic HLA compatibility and acute rejection in kidney transplantation 32
Alleli HLA-DQ alfa nella sclerosi multipla 32
IFNbeta therapy dose makes functional efficiency differences in Multiple Sclerosis patients 32
Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer 32
Analisi del linkage disequilibrium tra antigeni HLA di classe II in un campione della popolazione abruzzese. 32
HLA DPB1 allaele is strongly associated to DR3 in coeliac disease 31
The study of patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer. 31
Genotyping analysis of HLA Class II genes in Donor- Recipient Kidney Transplants Pairs 30
Immunological study of IFNbeta-1a treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapy 30
HLA-DP?1 allele is strongly associated to DR3 in coeliac disease 30
IFNbeta therapy dose makes functional efficiency differences in Multiple Sclerosis patienst 30
Immunological mechanisms in the establishment and progression of colon caner 30
Bcl-2 and drugs used in the treatment of cancer: New strategies of biotherapy which should not be underestimated. 29
Marcatori di linfociti nell'anziano in emodialisi periodica 29
Analisi del DNA heteroduplex per il locus HLA-DP nel trapianto di midollo osseo. 29
Differenze nel Locus HLA-DPB1 e risposta umorale nel trapianto di rene da donatore cadavere. 29
CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance: The role of IFN beta-1a in the treatment of multiple sclerosis 29
The immunological implications of gene alterations in the progression of colorectal cancer: indications for prognosis, treatment and tumor understanding. 28
Oncogeni e metastasi linfonodali in tumori primitivi del cavo orale 28
Prognostic indices for the early classification of colon cancer stage 27
Prognostic indices for the early classification of colon cancer stage. 27
Immunological implications of alterations in the c-ki-ras and p53 gene in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding. 27
Immunological implications of alterations in the c-ki-ras and p53 gene in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding 27
Associazione degli alleli HLA DR-DQ mediante tipizzazione genomica nella popolazione del centro-sud d'Italia. 27
Incompatibilità HLA-DPB1 e CLM in coppie di trapianto di midollo tra correlati e non correlati. 27
Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules 26
Ras family oncogenes in oral cancer 26
Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer 26
Relationships between the activity of MMPI/TIMPI enzymes and the TH1/TH2 cytokine network 26
Anticorpi anti HLA e anti EM nei pazienti uremici in attesa di trapianto renale 26
Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network. 26
DQalfa2,4 and DPbeta1 role in coeliac disease 25
Antigeni HLA ed epatopatie croniche alcooliche 25
MLC test and/or DNA typing in Bone Marrow transplantation 25
Genotyping analysis of HLA CLASS II genes in donor recipient kidney transplant pairs 25
Primary involvement of HLA DQA1 0501- DQB1 0201 heterodimer in celiac disease 25
p53 and K-ras genomic analysis in oral squamous cell carcinomas 25
Comparison between HLA-DR serological typing and oligotyping in kidney transplant: a single centre experience 25
IFNbeta-1a treatment and reestablishment of TH1 regulation in MS patients: dose effects. 24
Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network. 24
Primary involvment of HLA DQA1*0501-DQB1*0201 heterodimer in celiac disease 23
Identification of recombination event by DNA heteroduplex in a bone marrow transplant familiar study 23
A comparative study of HLA-DRB1 by serological, PCR-SSO and PCR-SSP methods in donor-recipient kidney transplantation pairs 23
Simultaneous measurement of sCEA and TIMP1 serum levels for use as pre-invasive to invasive markers of colorectal cancer. 23
Analisys of HLA-DP/DR-DQ linkage in a panel of unrelated bone marrow donors from a region of central Italy (Abruzzo). 23
Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions 23
Stadiazione genomica del cancro del colon e del retto. Biologia molecolare e citometria nel cancro del colon. 22
The TH1 And TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments. 22
Ras mutations is a rare event in oral squamous-cell carcinomas. 22
The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments 21
CD30: an important costimulator molecule in the regulation of the balance between TH1/TH2 response 21
HLA-DRB1 sequence- specific amplification (SSP) compared to PCR-SSO and serological methods in kidney transplantation 21
Elevata incidenza di alterazioni ras e p53 nei tumori del colon distale. 21
Analysis of ras mutations by PCR in oral and digestive cancer. 21
Analisi del linkage disequilibrium tra HLA-DP/DR-DQ in un campione della popolazione Abruzzese. 21
Polimorfismo HLA- DQalfa nel trapianto di midollo osseo 20
HLA Class II genomic polymorfism in multiple sclerosis: evaluation of DQA-DPB alleles 20
K-Ras mutations are a frequent event in distal colon carcinomas 19
The Directory of On-going Cancer Research in the European Union 19
HLA genomic typing, MLC reactivity and GVHD onset in related and unrelated bone marrow transplantation 19
HLA-DPB1 impact on MLC reactivity in bone marrow transplantation 19
Impact of DNA matching on acute rejection in renal transplantation 18
Componente gruppo-specifico nella Sclerosi Multipla. 18
HLA-DPB1*0402 disparity with a negative MLC reactivity elicited GVHD in bone marrow recipient by a HLA-A-B-DR and DQ compatible sibling: a case report. 17
K-ras mutations in different sites of colorectal cancer. 15
Totale 2.723
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.544
article - articoli 5.151
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.000
Totale 14.695
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202422 0 0 0 0 0 0 0 0 3 0 18 1
2024/20251.535 5 20 85 59 534 97 18 40 29 70 290 288
2025/20261.166 75 163 184 274 305 141 24 0 0 0 0 0
Totale 2.723